Skip to main content

Laron Syndrome - From Man to Mouse

Lessons from Clinical and Experimental Experience

  • Book
  • © 2011

Overview

  • First book covering this interesting topic, written by Zvi Laron who first described and reported the condition in 1966 (this syndrome is named after him)

  • Describes the comprehensive pathophysiology of IGF-I deficiency and gives valuable advice for the IGF-I treatment

  • Compares IGF-I and GH deficiency and illustrates the effects of the treatment, e.g. metabolic effects, adipose tissue alterations and the effects on aging

  • Includes supplementary material: sn.pub/extras

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (59 chapters)

  1. Clinical Aspects

Keywords

About this book

Laron syndrome (LS), or primary growth hormone (GH) insensitivity, was first described in 1966. Since then, many patients worldwide have been diagnosed with LS, which involves defects in the GH receptor that cause combined congenital deficiency of GH and IGF-I activities. In this comprehensive book the authors draw upon 50 years of multidisciplinary clinical and investigative follow-up of the large Israeli cohort of LS patients. The genetic basis of the syndrome is fully considered, and all aspects of the pathophysiology of IGF-I deficiency are described. Data derived from the recently generated mouse model of LS are reviewed and compared with the human LS experience. Valuable advice is provided on treatment, and treatment effects, such as metabolic effects, adipose tissue alterations, and impact on aging, are fully explored. Together, this book condenses, consolidates, compares, and contrasts data derived from the human and mouse LS experiences and provides a unique resource for clinical and basic scientists to evaluate and compare IGF-I and GH actions.

Editors and Affiliations

  • Endocrinology & Diabetes Research Unit, Schneider Children's Hospital, Petah Tikva, Israel

    Zvi Laron

  • Edison Biotechnology Institute, Ohio University, Athens, USA

    J. Kopchick

Bibliographic Information

  • Book Title: Laron Syndrome - From Man to Mouse

  • Book Subtitle: Lessons from Clinical and Experimental Experience

  • Editors: Zvi Laron, J. Kopchick

  • DOI: https://doi.org/10.1007/978-3-642-11183-9

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag Berlin Heidelberg 2011

  • Hardcover ISBN: 978-3-642-11182-2Due: 16 December 2010

  • Softcover ISBN: 978-3-662-50171-9Published: 23 August 2016

  • eBook ISBN: 978-3-642-11183-9Published: 25 November 2010

  • Edition Number: 1

  • Number of Pages: XIV, 531

  • Topics: Pediatrics, Endocrinology, Internal Medicine, Human Genetics, Molecular Medicine, Human Physiology

Publish with us